Bioclinica rebranded to Clario, but the numbers tell a different story. With 7,222 employees and $1.45B in revenue, this isn't just a pivot—it's a full-scale assault on the clinical trial data monopoly. The real question isn't what they do, but why they're flying under the radar despite dominating the industry.

"They're not selling software—they're selling the richest clinical evidence. That's a subtle but massive distinction."

What's fascinating is their keyword portfolio. 'bioclinica' still gets 6,080 monthly searches—legacy brand equity they're slowly migrating. But the real insight is 'websupport' ranking with 21,670 searches. This suggests they're either solving critical support issues or that their platform's support infrastructure is a major traffic driver. For enterprise software, that's unusually high support-related traffic.

• Enterprise-first strategy: 74% direct traffic proves deep customer lock-in
• Revenue-per-visit ratio of $41K reveals B2B scale few companies achieve
• Tech stack shows modernization: Tailwind CSS, Ant Design, Cloudflare
• The 'endpoint technology platform' positioning differentiates from point solutions
• Global workforce of 7,222 enables massive trial scale